Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Katherine Heath. (2018) Cost-effectiveness analysis of treatment timing considering the future entry of lower-cost generics for hepatitis C. ClinicoEconomics and Outcomes Research 10, pages 539-550.
Read now
Read now
Hye-Young Kwon, Hyungmin Kim, Brian Godman & Michael R Reich. (2015) The impact of South Korea’s new drug-pricing policy on market competition among off-patent drugs. Expert Review of Pharmacoeconomics & Outcomes Research 15:6, pages 1007-1014.
Read now
Read now
Faris El-Dahiyat, Reem Kayyali & Penelope Bidgood. (2014) Physicians’ perception of generic and electronic prescribing: A descriptive study from Jordan. Journal of Pharmaceutical Policy and Practice 7:1.
Read now
Read now
Mohammed Abuelkhair, Shajahan Abdu, Brian Godman, Sahar Fahmy, Rickard E Malmström & Lars L Gustafsson. (2012) Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi. Expert Review of Pharmacoeconomics & Outcomes Research 12:1, pages 115-124.
Read now
Read now
Steven Simoens. (2011) Biosimilar medicines and cost-effectiveness. ClinicoEconomics and Outcomes Research 3, pages 29-36.
Read now
Read now
Steven Simoens. (2008) Trends in generic prescribing and dispensing in Europe. Expert Review of Clinical Pharmacology 1:4, pages 497-503.
Read now
Read now
Steven Simoens. (2008) Generic medicine pricing in Europe: current issues and future perspective. Journal of Medical Economics 11:1, pages 171-175.
Read now
Read now
Steven Simoens. (2007) International comparison of generic medicine prices. Current Medical Research and Opinion 23:11, pages 2647-2654.
Read now
Read now
Panos Kanavos & David Taylor. (2007) Pharmacy discounts on generic medicines in France: is there room for further efficiency savings?. Current Medical Research and Opinion 23:10, pages 2467-2476.
Read now
Read now
Articles from other publishers (47)
Georges Hatem, Nare Navasardyan, Elsa Lahoud, Sanaa Awada, Rana Itani, Roula Ajrouche & Mathijs Goossens. (2022) Predictors of substitution to generic drugs and physicians’ perceived exclusivity of substitution: A cross sectional survey among physicians. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 19:1, pages 23-32.
Crossref
Crossref
António Augusto Donato, João Rui Pita & Francisco Batel-Marques. (2022) Classification of Pharmaceutical Policy Measures During the Portuguese Financial Crisis. INQUIRY: The Journal of Health Care Organization, Provision, and Financing 59, pages 004695802210931.
Crossref
Crossref
Zikria Saleem, Hamid Saeed, Zunaira Akbar, Amna Saeed, Saleha Khalid, Laiba Farrukh, Aleena Irfan, Azka Anam, Mohamed Azmi Hassali, Huma Rasheed & Zaheer-Ud-Din Babar. (2021) WHO key access antibiotics prices, availability and affordability in private sector pharmacies in Pakistan. Cost Effectiveness and Resource Allocation 19:1.
Crossref
Crossref
Wei-jie Li, Mei-jun Xia, Shi-wei Gong & Yu-feng Ding. (2021) Perceptions of Generic Drugs in the Pharmacists of Public Hospitals: A Cross-sectional Survey in Hubei Province of China. Current Medical Science 41:5, pages 987-995.
Crossref
Crossref
Sabine Vogler, Peter Schneider & Lena Lepuschütz. (2020) Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation. Cost Effectiveness and Resource Allocation 18:1.
Crossref
Crossref
M. Al Hussaini, N. Alsaffar & A. Abdulraheem. (2018) Exploring community pharmacists’ knowledge, perception and experiences towards branded and generic medicines in Kuwait: Highlighting the role of pharmacist. Bulletin of Faculty of Pharmacy, Cairo University 56:1, pages 109-114.
Crossref
Crossref
Mohamed Azmi Hassali & Zhi Yen Wong. 2018. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries
197
210
.
Zhi Yen Wong, Alian A. Alrasheedy, Mohamed Azmi Hassali & Fahad Saleem. (2017) Goods and Services Tax on Pharmaceuticals in Malaysia. Therapeutic Innovation & Regulatory Science 51:2, pages 221-223.
Crossref
Crossref
Hye-Young Kwon & Brian Godman. (2016) Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications. BMC Health Services Research 16:1.
Crossref
Crossref
Sudesh Gyawali, Mohamed Azmi Hassali & Archana Saha. (2016) A survey exploring the knowledge and perceptions of senior medical students in Nepal toward generic medicines. SAGE Open Medicine 4, pages 205031211666257.
Crossref
Crossref
Mohammad Bashaar, Mohamed Azmi Hassali & Fahad Saleem. (2015) Community pharmacists’ attitudes toward the quality and price of locally manufactured generic medicines in Kabul, Afghanistan. Journal of Pharmaceutical Policy and Practice 8:1.
Crossref
Crossref
Zhi Y Wong, Mohamed A Hassali, Alian A Alrasheedy, Fahad Saleem, Abdul Haniff M Yahaya, Hisham Aljadhey & Tahir M Khan. (2015) Medical specialists' knowledge, perceptions and views about generic medicines in Malaysia: Findings from a qualitative study and the implications. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 12:2, pages 60-73.
Crossref
Crossref
Fumiyo Nakagawa, Alec Miners, Colette J. Smith, Ruth Simmons, Rebecca K. Lodwick, Valentina Cambiano, Jens D. Lundgren, Valerie Delpech & Andrew N. Phillips. (2015) Projected Lifetime Healthcare Costs Associated with HIV Infection. PLOS ONE 10:4, pages e0125018.
Crossref
Crossref
Mohamed Azmi Hassali, Ching Siang Tan, Zhi Yen Wong, Fahad Saleem & Alian A. Alrasheedy. 2015. Pharmaceutical Prices in the 21st Century. Pharmaceutical Prices in the 21st Century
171
188
.
Zhi Yen Wong, Mohamed Azmi Hassali, Alian A. Alrasheedy, Fahad Saleem, Abdul Haniff Mohamad Yahaya & Hisham Aljadhey. (2014) Malaysian generic pharmaceutical industries: perspective from healthcare stakeholders. Journal of Pharmaceutical Health Services Research 5:4, pages 193-203.
Crossref
Crossref
Mohamed Azmi Hassali, Alian A. Alrasheedy, Andrew McLachlan, Tuan Anh Nguyen, Saleh Karamah AL-Tamimi, Mohamed Izham Mohamed Ibrahim & Hisham Aljadhey. (2014) The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use. Saudi Pharmaceutical Journal 22:6, pages 491-503.
Crossref
Crossref
Javier Jerez-Roig, Lucas F. B. Medeiros, Victor A. B. Silva, Camila L. P. A. M. Bezerra, Leandro A. R. Cavalcante, Grasiela Piuvezam & Dyego L. B. Souza. (2014) Prevalence of Self-Medication and Associated Factors in an Elderly Population: A Systematic Review. Drugs & Aging 31:12, pages 883-896.
Crossref
Crossref
Mohamed Azmi Hassali, Zhi Yen Wong, Alian A. Alrasheedy, Fahad Saleem, Abdul Haniff Mohamad Yahaya & Hisham Aljadhey. (2014) Perspectives of physicians practicing in low and middle income countries towards generic medicines: A narrative review. Health Policy 117:3, pages 297-310.
Crossref
Crossref
Mohamed Azmi Hassali, Zhi Yen Wong, Alian A. Alrasheedy, Fahad Saleem, Abdul Haniff Mohamad Yahaya & Hisham Aljadhey. (2014) Does educational intervention improve doctors’ knowledge and perceptions of generic medicines and their generic prescribing rate? A study from Malaysia. SAGE Open Medicine 2, pages 205031211455572.
Crossref
Crossref
Ahmed Awaisu, Nadir Kheir, Mohamed Izham Mohamed Ibrahim, Maguy El-Hajj, Huda Hazi, Nada Khudair & Raja Barazi. (2014) Knowledge, attitudes, and practices of community pharmacists on generic medicines in Qatar. International Journal of Clinical Pharmacy 36:2, pages 394-404.
Crossref
Crossref
Zhi Yen Wong, Mohamed Azmi Hassali, Fahad Saleem, Abdul Haniff Mohamad Yahaya & Hisham Aljadhey. (2014) Translation and validation of the Malaysian version of generic medicines scale. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing 14:1, pages 32-40.
Crossref
Crossref
Sarah J. Mansfield. (2014) Generic drug prices and policy in Australia: room for improvement? A comparative analysis with England. Australian Health Review 38:1, pages 6.
Crossref
Crossref
Suzanne Dunne, Bill Shannon, Colum Dunne & Walter Cullen. (2013) A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacology and Toxicology 14:1.
Crossref
Crossref
Salmiah Mohd Ali, Mohamed Mansor Manan, Mohamed Azmi Hassali, Yaman Walid Kassab, Choon Wai Yee & Masidah Binti Masri. (2013) Use of generic medicines: Perspectives of consumers living in urban and suburban areas of Klang Valley in Malaysia. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing 13:4, pages 242-250.
Crossref
Crossref
Yusi Anggriani, Mohamed Izham M Ibrahim, Sri Suryawati & Asrul A Shafie. (2014) The impact of Indonesian generic medicine pricing policy on medicine prices. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 10:3-4, pages 219-229.
Crossref
Crossref
Faris Abdelrahim El-Dahiyat & Reem Kayyali. (2013) Community pharmacists’ perceptions towards generic medicines and their opinions on future generic substitution policy implementation: A descriptive study from Jordan. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 10:2, pages 97-104.
Crossref
Crossref
Jaume Puig-Junoy. (2012) Do Higher-Priced Generic Medicines Enjoy a Competitive Advantage Under Reference Pricing?. Applied Health Economics and Health Policy 10:6, pages 441-451.
Crossref
Crossref
Valentina Fabiano, Chiara Mameli, Dario Cattaneo, Antonella Delle Fave, Alessandra Preziosa, Giuseppe Mele, Emilio Clementi & Gian Vincenzo Zuccotti. (2012) Perceptions and patterns of use of generic drugs among Italian Family Pediatricians: First round results of a web survey. Health Policy 104:3, pages 247-252.
Crossref
Crossref
Paul Cornes. (2012) The economic pressures for biosimilar drug use in cancer medicine. Targeted Oncology 7:S1, pages 57-67.
Crossref
Crossref
M. S. Aapro. (2012) What do prescribers think of biosimilars?. Targeted Oncology 7:S1, pages 51-55.
Crossref
Crossref
Petros Pechlivanoglou, Willem Jan van der Veen, Jens H Bos & Maarten J Postma. (2011) Analyzing generic and branded substitution patterns in the Netherlands using prescription data. BMC Health Services Research 11:1.
Crossref
Crossref
Anne Decollogny, Yves Eggli, Patricia Halfon & Thomas M Lufkin. (2011) Determinants of generic drug substitution in Switzerland. BMC Health Services Research 11:1.
Crossref
Crossref
Pieter Dylst & Steven Simoens. (2011) Does the Market Share of Generic Medicines Influence the Price Level?. PharmacoEconomics 29:10, pages 875-882.
Crossref
Crossref
Zaheer-Ud-Din Babar, Piyush Grover, Joanna Stewart, Michele Hogg, Leanne Short, Hee Gyung Seo & Anne Rew. (2011) Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand. Research in Social and Administrative Pharmacy 7:3, pages 294-305.
Crossref
Crossref
P. Cornes. (2011) The economic pressures for biosimilar drug use in cancer medicineLes pressions économiques en faveur de l’utilisation des biosimilaires en oncologie. Oncologie 13:5, pages 222-233.
Crossref
Crossref
M. S. Aapro. (2011) What does a prescriber think of biosimilars?Biosimilaires: qu’en pense le prescripteur ?. Oncologie 13:5, pages 234-238.
Crossref
Crossref
Brian Godman, William Shrank, Bjorn Wettermark, Morten Andersen, Iain Bishop, Thomas Burkhardt, Kristina Garuolienè, Marija Kalaba, Ott Laius, Roberta Joppi, Catherine Sermet, Ulrich Schwabe, Inês Teixeira, F. Cankat Tulunay, Kamila Wendykowska, Corinne Zara & Lars L Gustafsson. (2010) Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?. Pharmaceuticals 3:8, pages 2470-2494.
Crossref
Crossref
Jaume Puig-Junoy. (2010) Impact of European Pharmaceutical Price Regulation on Generic Price Competition. PharmacoEconomics 28:8, pages 649-663.
Crossref
Crossref
Zaheer-Ud-Din Babar, Joanna Stewart, Shiwangni Reddy, Woroud Alzaher, Prateeka Vareed, Nineweh Yacoub, Bandhana Dhroptee & Anne Rew. (2010) An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Auckland. Pharmacy World & Science 32:4, pages 440-448.
Crossref
Crossref
Debbie Duncan. (2010) Generic prescribing and substitution: the big issues. British Journal of Community Nursing 15:5, pages 248-249.
Crossref
Crossref
Gin Nie Chua, Mohamed Azmi Hassali, Asrul Akmal Shafie & Ahmed Awaisu. (2010) A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy 95:2-3, pages 229-235.
Crossref
Crossref
Jaume Puig-Junoy. (2010) Políticas de fomento de la competencia en precios en el mercado de genéricos: lecciones de la experiencia europea. Gaceta Sanitaria 24:3, pages 193-199.
Crossref
Crossref
Pieter Dylst & Steven Simoens. (2010) Generic Medicine Pricing Policies in Europe: Current Status and Impact. Pharmaceuticals 3:3, pages 471-481.
Crossref
Crossref
V. Tsiantou, D. Zavras, H. Kousoulakou, M. Geitona & J. Kyriopoulos. (2009) Generic medicines: Greek physicians’ perceptions and prescribing practices. Journal of Clinical Pharmacy and Therapeutics 34:5, pages 547-554.
Crossref
Crossref
Asrul Akmal Shafie & Mohamed Azmi Hassali. (2008) Price Comparison between Innovator and Generic Medicines Sold by Community Pharmacies in the State of Penang, Malaysia. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 6:1, pages 35-42.
Crossref
Crossref
Panos Kanavos, Joan Costa-Font & Elizabeth Seeley. (2008) Competition in off-patent drug markets: Issues, regulation and evidence. Economic Policy 23:55, pages 499-544.
Crossref
Crossref
. (2013) Does the UK NHS get a good deal from generic drug purchasing?. PharmacoEconomics & Outcomes News 524:1, pages 10-10.
Crossref
Crossref